Ethamolin

This page contains recent news articles, when available, and an overview of Ethamolin but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Overview:

Ethamolin (when available)

Pharmacology and use:
Alcohol produces injury to cells by dehydration and precipitation of the cytoplasm or protoplasm. This accounts for its bacteriocidal and antifungal action. When alcohol is injected in close proximity to nerve tissues, it produces neuritis and nerve degeneration (neurolysis). Ninety to 98% of ethanol that enters the body is completely oxidized. Ethanol is also used as a cosolvent to dissolve many insoluble drugs and to serve as a mild sedative in some medicinal formulations. For therapeutic neurolysis of nerves or ganglia for the relief of intractable chronic pain in such conditions as inoperable cancer and trigeminal neuralgia (tic douloureux), in patients for whom neurosurgical procedures are contraindicated.

Mechanism Of Action:
The sedative effects of ethanol are mediated through binding to GABA receptors and glycine receptors (alpha 1 and alpha 2 subunits). In its role as an anti-infective, ethanol acts as an osmolyte or dehydrating agent that disrupts the osmotic balance across cell membranes.

News Articles on Ethanol

Financial Results for the Quarter Ended December 31, 2004  -  Mar 9, 2005
Net product sales of Acthar, Ethamolin and VSL#3 were also higher as ... Ethamolin sales increased in the fourth quarter of 2004, after declining over the ... Free with registration - Business Wire - AccessMyLibrary.com

Questcor Announces Financial Results for First Quarter 2005  -  Mar 31, 2005
These decreases were partially offset by first quarter Ethamolin sales which increased substantially over the previous quarter. First quarter net product ... businesswire.com

Questcor Announces Financial Results for First Quarter 2005.  -  May 10, 2005
These decreases were partially offset by first quarter Ethamolin sales which increased substantially over the previous quarter. First quarter net product ... $4.95 - Business Wire - ECNext

Questcor Announces Financial Results for the First Quarter of 2006;...  -  May 9, 2006
As previously reported, Questcor sold its non-core products Nascobal, Ethamolin, and Glofil-125 in October 2005 to focus its promotional efforts on Acthar ... Free with registration - Business Wire - AccessMyLibrary.com

Questcor Announces Financial Results for the First Quarter of 2006;...  -  Mar 31, 2006
As previously reported, Questcor sold its non-core products Nascobal, Ethamolin, and Glofil-125 in October 2005 to focus its promotional efforts on Acthar ... businesswire.com

Questcor Announces Financial Results for 2005 and the Expansion of...  -  Dec 31, 2005
2005 Questcor completed the sale of its Nascobal(R), Ethamolin(R) and ... but less than one month of net product sales of Nascobal, Ethamolin and ... businesswire.com

Questcor Announces Financial Results for 2005 and the Expansion of...  -  Mar 9, 2006
2005 Questcor completed the sale of its Nascobal(R), Ethamolin(R) and ... but less than one month of net product sales of Nascobal, Ethamolin and ... $4.95 - Business Wire - ECNext

Questcor Announces Financial Results for Second Quarter 2005.  -  Aug 11, 2005
Approximately $550000 in orders for Acthar, Nascobal and Ethamolin(R) were received in March 2005 and shipped in April 2005. The revenue from these orders, ... $4.95 - Business Wire - ECNext

Questcor Completes Divestiture of Three Products for .3 Million -...  -  Oct 17, 2005
Questcor completed the sale of its Nascobal(R), Ethamolin(R) and Glofil(R)-125 products to QOL Medical LLC for $28.3 million, plus the assumption by QOL of ... RedOrbit

Questcor Announces Financial Results for 2006 Second Quarter; Sales...  -  Aug 8, 2006
These changes primarily included the sale of Questcor's non-core products Nascobal(R), Ethamolin(R) and Glofil(R)-125 and the retirement of Questcor's ... $4.95 - Business Wire - ECNext

Bellwether Report .com is following Questcor Pharmaceuticals, Inc.  -  Aug 2, 2006
These include Nascobal, which treats vitamin B-12 deficiencies, Ethamolin, which treats esophageal bleeding associated with liver disease, and Glofil-125, ... $4.95 - M2 Presswire - ECNext

Questcor Announces the Addition of George Stuart As Chief Financial …  -  Sep 28, 2005
...such as bariatric surgery, Crohn's disease and certain neurological conditions; Ethamolin(R) (Ethanolamine Oleate), an injectable drug used to treat ... RedOrbit

Questcor to Announce New Strategic Focus - Final.  -  Apr 13, 2005
Ethamolin and Glofil, which are not directly related to the CNS area, will continue to be maintained through limited, non-manpower promotion. ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com

Questcor Announces Financial Results for Second Quarter 2005  -  Jun 30, 2005
Approximately $550000 in orders for Acthar, Nascobal and Ethamolin(R) were received in March 2005 and shipped in April 2005. The revenue from these orders, ... businesswire.com

Questcor Announces Financial Results for Third Quarter 2005  -  Sep 30, 2005
Questcor completed the sale of its Nascobal(R), Ethamolin(R) and Glofil(R)-125 products to QOL Medical LLC (QOL) for gross proceeds of $28300000, ... businesswire.com

Questcor Names James L. Fares President and CEO.  -  Feb 23, 2005
...such as bariatric surgery, Crohn's disease and certain neurological conditions; Ethamolin(R) (Ethanolamine Oleate), an injectable drug used to treat ... $4.95 - Business Wire - ECNext

Questcor to Retire 8% Debentures Following Restructuring of Dividends...  -  Apr 1, 2005
...such as bariatric surgery, Crohn's disease and certain neurological conditions; Ethamolin(R) (Ethanolamine Oleate), an injectable drug used to treat ... $4.95 - Business Wire - ECNext

Questcor Updates Revenue Guidance for 2004 and Reports on Progress …  -  Feb 18, 2005
...(repository corticotropin injection), an injectable drug that is commonly used for certain neurological conditions; Ethamolin(R) (Ethanolamine Oleate), ... $4.95 - Business Wire - ECNext

Questcor Appoints Gregg Lapointe to Its Board of Directors.  -  Jul 6, 2005
...such as bariatric surgery, Crohn's disease and certain neurological conditions; Ethamolin(R) (Ethanolamine Oleate), an injectable drug used to treat ... $4.95 - Business Wire - ECNext

Questcor Announces First Quarter Earnings Call.  -  May 9, 2005
...such as bariatric surgery, Crohn's disease and certain neurological conditions; Ethamolin(R) (Ethanolamine Oleate), an injectable drug used to treat ... $4.95 - Business Wire - ECNext

Questcor Announces the Addition of Steve Cartt as Executive Vice …  -  Mar 15, 2005
...such as bariatric surgery, Crohn's disease and certain neurological conditions; Ethamolin(R) (Ethanolamine Oleate), an injectable drug used to treat ... $4.95 - Business Wire - ECNext

Questcor Announces the Addition of Craig Chambliss as Vice President...  -  May 2, 2005
...such as bariatric surgery, Crohn's disease and certain neurological conditions; Ethamolin(R) (Ethanolamine Oleate), an injectable drug used to treat ... $4.95 - Business Wire - ECNext

Questcor Announces FDA Approval of Acthar API Manufacturing Transfer.  -  Jun 29, 2005
...such as bariatric surgery, Crohn's disease and certain neurological conditions; Ethamolin(R) (Ethanolamine Oleate), an injectable drug used to treat ... $4.95 - Business Wire - ECNext

Questcor Announces Year End Earnings Call.  -  Mar 7, 2005
...such as bariatric surgery, Crohn's disease and certain neurological conditions; Ethamolin(R) (Ethanolamine Oleate), an injectable drug used to treat ... $4.95 - Business Wire - ECNext

Questcor Announces Second Quarter Earnings Call.  -  Aug 9, 2005
...such as bariatric surgery, Crohn's disease and certain neurological conditions; Ethamolin(R) (Ethanolamine Oleate), an injectable drug used to treat ... $4.95 - Business Wire - ECNext

Questcor to Announce New Strategic Focus.  -  Apr 11, 2005
...such as bariatric surgery, Crohn's disease and certain neurological conditions; Ethamolin(R) (Ethanolamine Oleate), an injectable drug used to treat ... $4.95 - Business Wire - ECNext

Questcor to Webcast Annual Meeting Presentation.  -  May 31, 2005
...such as bariatric surgery, Crohn's disease and certain neurological conditions; Ethamolin(R) (Ethanolamine Oleate), an injectable drug used to treat ... $4.95 - Business Wire - ECNext

Brand Names/Synonyms:
Ethamolin is also known by the following brand names and/or synonymsAbsolute Alcohol; Absolute Ethanol; Aethanol; Aethylalkohol; Alcare Hand Degermer; Alcohol; Alcohol Anhydrous; Alcohol, Anhydrous; Alcohol, Anhydrous Acs Grade; Alcohol, Dehydrated; Alcohol, Diluted; Alcohols; Alcool Ethylique; Alcool Etilico; Algrain; Alkohol; Alkoholu Etylowego; Aminoethanol; Anhydrol; Beta-Aminoethanol; Beta-Aminoethyl Alcohol; Beta-Ethanolamine; Beta-Hydroxyethylamine; C2H5OH; CCRIS 6260; Caswell No. 426; Colamine; Cologne Spirit; Cologne Spirits; Dehydrated Ethanol; Denatured Alcohol; Denatured Alcohol Cd-10; Denatured Alcohol Cd-5; Denatured Alcohol Cd-5a; Denatured Alcohol Sd-1; Denatured Alcohol Sd-13a; Denatured Alcohol Sd-17; Denatured Alcohol Sd-23a; Denatured Alcohol Sd-28; Denatured Alcohol Sd-30; Denatured Alcohol Sd-39b; Denatured Alcohol Sd-39c; Denatured Alcohol Sd-3a; Denatured Alcohol Sd-40m; Denatured Ethanol; ETA; ETHANOL 95%; ETHANOL 96%; Envision Conditioner Pdd 9020; Etanolo; Ethamolin; Ethanol; Ethanol 200 Proof; Ethanol 95% V/V; Ethanol 96% Bp; Ethanol 96% V/V; Ethanol Absolute; Ethanol Absolute - Duty Free; Ethanol Absolute Bp; Ethanol Anhydrous; Ethanol Extra Pure; Ethanol, Silent Spirit; Ethanol, Solution; Ethyl Alc; Ethyl Alcohol; Ethyl Alcohol & Water, 10%; Ethyl Alcohol & Water, 20%; Ethyl Alcohol & Water, 30%; Ethyl Alcohol & Water, 40%; Ethyl Alcohol & Water, 5%; Ethyl Alcohol & Water, 50%; Ethyl Alcohol & Water, 60%; Ethyl Alcohol & Water, 70%; Ethyl Alcohol & Water, 80%; Ethyl Alcohol & Water, 95%; Ethyl Alcohol & Water, 96%; Ethyl Alcohol Anhydrous; Ethyl Alcohol, Anhydrous; Ethyl Alcohol, Denatured; Ethyl Hydrate; Ethyl Hydroxide; Ethylol; Ethylolamine; Etoh; Etylowy Alkohol; Fermentation Alcohol; Glycinol; Grain Alcohol; HSDB 531; Jaysol; Jaysol S; MEA; Methylated Spirit Mineralised; Methylcarbinol; Molasses Alcohol; Monoethanolamine; NCI-C03134; Olamine; Phenyl J-Acid; Potato Alcohol; Punctilious Ethyl Alcohol; Pyro; Reagent Alcohol; Spirit; Spirits of Wine; Spirt; Synasol; Tecsol; Tecsol C; Thanol; Thiofaco M-50; UN 1170; UN2491; USAF EK-1597; Usi in Oval

Drug Category:
Ethamolin is categorized under the following by the FDA: Solvents; Anti-Infective Agents, Local; Central Nervous System Depressants; Disinfectants; ATC:C05BB01; ATC:D01AE06; ATC:D08AX08; ATC:V03AB16; ATC:V03AZ01

Dosage Forms:
LIQUID

Absorption:
Rapidly absorbed.

Interactions:
[an error occurred while processing this directive]

Chemical IUPAC Name:
ethanol

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.